https://pharmadog.xyz/news/455856 pharmadog en 2026-09-26T22:17:00.000Z Mezzetta voluntarily recalls 32-oz Golden Greek Peperoncini after pest contaminant found in jar https://pharmadog.xyz/news/459187 pharmadog en 2026-09-26T16:01:44.000Z FDA greenlights AbbVie’s next-generation Parkinson’s drug tavapadon (Juvmo) with expected lower side effects https://pharmadog.xyz/news/458115 pharmadog en 2026-09-26T11:00:00.000Z Former CDC investigator warns that gaps in public-health readiness leave the U.S. vulnerable to future biothreats https://pharmadog.xyz/news/458071 pharmadog en 2026-09-26T10:00:48.000Z Endpoints Weekly returns with new class unveiled at Boston gala https://pharmadog.xyz/news/456387 pharmadog en 2026-09-26T01:03:38.000Z Trump administration cancels nearly $1 billion of congressional spending, targeting refugee and immigrant services https://pharmadog.xyz/news/455119 pharmadog en 2026-09-25T19:46:36.000Z FDA approves Mirum's Atebrioz for ultra-rare disease that hardens muscle and connective tissue https://pharmadog.xyz/news/454827 pharmadog en 2026-09-25T17:50:04.000Z UN-backed agency secures sub-licensing deals for generic Roche flu drug across 129 low- and middle-income countries https://pharmadog.xyz/news/454695 pharmadog en 2026-09-25T17:05:24.000Z Jury awards Nektar $90 million in lawsuit against Eli Lilly over licensing dispute https://pharmadog.xyz/news/454527 pharmadog en 2026-09-25T16:51:20.000Z Pharma groups urge FDA to clarify criteria for approving drugs based on a single pivotal trial https://pharmadog.xyz/news/454591 pharmadog en 2026-09-25T16:08:00.000Z Novo’s stock tumbles after two-year GLP-1 boom as AI drug-discovery startups land huge funding rounds https://pharmadog.xyz/news/454359 pharmadog en 2026-09-25T15:41:48.000Z Experts say expanding beyond rare disease markets can make ultra-rare therapies financially viable https://pharmadog.xyz/news/454403 pharmadog en 2026-09-25T15:25:10.000Z FDA approves Lilly's once-weekly basal insulin Onswik for adults with type 2 diabetes https://pharmadog.xyz/news/454215 pharmadog en 2026-09-25T14:49:45.000Z Biomanufacturers Redesign Processes to Blend Emergency Vaccine Readiness with Commercial Flexibility https://pharmadog.xyz/news/454191 pharmadog en 2026-09-25T14:34:34.000Z Legend's five-year data suggests Carvykti could be a cure; Addex, Indivior split https://pharmadog.xyz/news/454216 pharmadog en 2026-09-25T14:04:34.000Z Jury awards Nektar $90 million in damages after lawsuit over broken rezpeg partnership with Eli Lilly https://pharmadog.xyz/news/454192 pharmadog en 2026-09-25T14:00:59.000Z Kali Therapeutics pivots from Chinese drug acquisitions to focus on its own growing pipeline https://pharmadog.xyz/news/454193 pharmadog en 2026-09-25T14:00:58.000Z Azalea Therapeutics wins Endpoints 11 award, combines gene editing with CAR-T and raises $82 million https://pharmadog.xyz/news/454194 pharmadog en 2026-09-25T14:00:55.000Z NewLimit raises $682M to pursue new class of anti-aging drugs https://pharmadog.xyz/news/454195 pharmadog en 2026-09-25T14:00:54.000Z Anew Labs, ByteDance’s biotech spinout, raises $290M to build a China AI bio rival https://pharmadog.xyz/news/454196 pharmadog en 2026-09-25T14:00:53.000Z Stipple Bio wins Endpoints 2026 award for precision pancreatic cancer therapy https://pharmadog.xyz/news/454197 pharmadog en 2026-09-25T14:00:51.000Z Medra, 2026 Endpoints 11 winner, aims to build self-driving labs https://pharmadog.xyz/news/454198 pharmadog en 2026-09-25T14:00:42.000Z SonoThera secures $186 million to advance non-viral gene-therapy platform https://pharmadog.xyz/news/454199 pharmadog en 2026-09-25T14:00:38.000Z Medici wins Endpoints 2026 award, touts personalized cancer therapy https://pharmadog.xyz/news/454200 pharmadog en 2026-09-25T14:00:31.000Z Corsera wins Endpoints 11 2026 award, marking a major bet by veteran biotech leaders Meanwell and Maraganore https://pharmadog.xyz/news/454201 pharmadog en 2026-09-25T14:00:30.000Z Endpoints 11 showcases top biotech startups, signaling renewed optimism and funding https://pharmadog.xyz/news/454202 pharmadog en 2026-09-25T14:00:22.000Z K2 Therapeutics seeks to blend China’s speed with global expertise after winning Endpoints 2026 award https://pharmadog.xyz/news/454203 pharmadog en 2026-09-25T14:00:06.000Z Vivodyne’s Human Tissue Factory Wins Endpoints 11 2026, Promising Faster Drug Testing https://pharmadog.xyz/news/454067 pharmadog en 2026-09-25T13:38:18.000Z Rakuten Medical appoints Hassan Danesi as chief medical officer, coming from Coherus Biosciences https://pharmadog.xyz/news/454047 pharmadog en 2026-09-25T13:34:11.000Z ADARx raises $446 million in one of 2026's largest biotech IPOs as City Therapeutics plans its own listing https://pharmadog.xyz/news/454048 pharmadog en 2026-09-25T13:25:46.000Z Carvykti shows 5-year survival in half of multiple myeloma patients in Phase 2 study https://pharmadog.xyz/news/454087 pharmadog en 2026-09-25T13:21:00.000Z Novo signs €1.2 bn deal with Nanexa for long-acting injectables as Acadia’s Alzheimer trial misses target